Annual CFF
$7.51 M
-$32.19 M-81.09%
May 26, 2024
Summary
- As of February 7, 2025, LFCR annual cash flow from financing activities is $7.51 million, with the most recent change of -$32.19 million (-81.09%) on May 26, 2024.
- During the last 3 years, LFCR annual CFF has risen by +$10.93 million (+319.63%).
- LFCR annual CFF is now -90.50% below its all-time high of $79.03 million, reached on May 1, 2019.
Performance
LFCR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$12.52 M
+$11.42 M+1045.01%
November 24, 2024
Summary
- As of February 7, 2025, LFCR quarterly cash flow from financing activities is $12.52 million, with the most recent change of +$11.42 million (+1045.01%) on November 24, 2024.
- Over the past year, LFCR quarterly CFF has increased by +$4.88 million (+63.87%).
- LFCR quarterly CFF is now -79.69% below its all-time high of $61.60 million, reached on February 1, 2019.
Performance
LFCR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$20.63 M
+$14.96 M+263.99%
November 24, 2024
Summary
- As of February 7, 2025, LFCR TTM cash flow from financing activities is $20.63 million, with the most recent change of +$14.96 million (+263.99%) on November 24, 2024.
- Over the past year, LFCR TTM CFF has dropped by -$12.06 million (-36.90%).
- LFCR TTM CFF is now -78.92% below its all-time high of $97.89 million, reached on November 1, 2019.
Performance
LFCR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
LFCR Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -81.1% | +63.9% | -36.9% |
| 3 y3 years | +319.6% | +63.9% | -36.9% |
| 5 y5 years | -90.5% | -16.9% | -31.7% |
LFCR Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -81.1% | +113.2% | -49.1% | +126.6% | -48.0% | +129.8% |
| 5 y | 5-year | -90.5% | +113.2% | -49.1% | +126.6% | -48.4% | +129.8% |
| alltime | all time | -90.5% | +113.2% | -79.7% | +126.6% | -78.9% | +129.8% |
Lifecore Biomedical Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2024 | - | $12.52 M(+1045.0%) | $20.63 M(+264.0%) |
| Aug 2024 | - | $1.09 M(-278.0%) | $5.67 M(-24.5%) |
| May 2024 | $7.51 M(-81.1%) | -$614.00 K(-108.0%) | $7.51 M(-77.0%) |
| Feb 2024 | - | $7.64 M(-412.0%) | $32.69 M(+19.0%) |
| Nov 2023 | - | -$2.45 M(-183.4%) | $27.47 M(-29.1%) |
| Aug 2023 | - | $2.93 M(-88.1%) | $38.73 M(-2.4%) |
| May 2023 | $39.70 M(-169.6%) | $24.57 M(+917.9%) | $39.70 M(+15.8%) |
| Feb 2023 | - | $2.41 M(-72.6%) | $34.27 M(-324.9%) |
| Nov 2022 | - | $8.81 M(+125.5%) | -$15.24 M(+7.5%) |
| Aug 2022 | - | $3.91 M(-79.6%) | -$14.17 M(-75.2%) |
| May 2022 | -$57.02 M(+1567.8%) | $19.14 M(-140.6%) | -$57.02 M(-17.6%) |
| Feb 2022 | - | -$47.09 M(-576.7%) | -$69.17 M(+559.2%) |
| Nov 2021 | - | $9.88 M(-125.4%) | -$10.49 M(-58.6%) |
| Aug 2021 | - | -$38.95 M(-657.4%) | -$25.34 M(+641.2%) |
| May 2021 | -$3.42 M(-108.5%) | - | - |
| May 2021 | - | $6.99 M(-39.7%) | -$3.42 M(-174.1%) |
| Feb 2021 | - | $11.59 M(-333.1%) | $4.62 M(-135.4%) |
| Nov 2020 | - | -$4.97 M(-70.8%) | -$13.05 M(-287.0%) |
| Aug 2020 | - | -$17.02 M(-213.3%) | $6.98 M(-82.6%) |
| May 2020 | $40.02 M(-49.4%) | $15.02 M(-347.2%) | $40.02 M(+32.5%) |
| Feb 2020 | - | -$6.08 M(-140.4%) | $30.21 M(-69.1%) |
| Nov 2019 | - | $15.06 M(-6.0%) | $97.89 M(+16.1%) |
| Aug 2019 | - | $16.02 M(+207.3%) | $84.32 M(+6.7%) |
| May 2019 | $79.03 M(+494.5%) | $5.21 M(-91.5%) | $79.03 M(-4.1%) |
| Feb 2019 | - | $61.60 M(+4031.8%) | $82.42 M(+284.9%) |
| Nov 2018 | - | $1.49 M(-86.1%) | $21.41 M(+20.2%) |
| Aug 2018 | - | $10.72 M(+24.6%) | $17.81 M(+34.0%) |
| May 2018 | $13.29 M(-251.0%) | $8.61 M(+1334.2%) | $13.29 M(+95.1%) |
| Feb 2018 | - | $600.00 K(-128.4%) | $6.81 M(+99.4%) |
| Nov 2017 | - | -$2.11 M(-134.1%) | $3.42 M(+13.4%) |
| Aug 2017 | - | $6.20 M(+191.7%) | $3.01 M(-134.2%) |
| May 2017 | -$8.80 M(-157.1%) | $2.13 M(-176.0%) | -$8.80 M(-12.4%) |
| Feb 2017 | - | -$2.80 M(+11.0%) | -$10.04 M(-669.3%) |
| Nov 2016 | - | -$2.52 M(-55.1%) | $1.76 M(-84.9%) |
| Aug 2016 | - | -$5.61 M(-735.0%) | $11.67 M(-24.3%) |
| May 2016 | $15.42 M(+100.1%) | $884.00 K(-90.2%) | $15.42 M(+123.9%) |
| Feb 2016 | - | $9.01 M(+21.9%) | $6.89 M(+854.2%) |
| Nov 2015 | - | $7.39 M(-496.7%) | $722.00 K(+79.6%) |
| Aug 2015 | - | -$1.86 M(-75.6%) | $402.00 K(-94.8%) |
| May 2015 | $7.71 M(-207.3%) | -$7.65 M(-369.0%) | $7.71 M(-45.3%) |
| Feb 2015 | - | $2.84 M(-59.8%) | $14.10 M(+23.2%) |
| Nov 2014 | - | $7.07 M(+30.0%) | $11.44 M(+224.7%) |
| Aug 2014 | - | $5.44 M(-531.5%) | $3.52 M(-149.1%) |
| May 2014 | -$7.18 M(-62.7%) | -$1.26 M(-760.2%) | -$7.18 M(-8.0%) |
| Feb 2014 | - | $191.00 K(-122.6%) | -$7.80 M(-28.5%) |
| Nov 2013 | - | -$847.00 K(-83.9%) | -$10.91 M(+8.0%) |
| Aug 2013 | - | -$5.26 M(+179.0%) | -$10.10 M(-47.6%) |
| May 2013 | -$19.27 M(-153.6%) | -$1.89 M(-35.3%) | -$19.27 M(-188.3%) |
| Feb 2013 | - | -$2.92 M(+7571.1%) | $21.83 M(-14.3%) |
| Nov 2012 | - | -$38.00 K(-99.7%) | $25.47 M(+20.1%) |
| Aug 2012 | - | -$14.43 M(-136.8%) | $21.21 M(-41.0%) |
| May 2012 | $35.93 M(-854.3%) | $39.21 M(+5271.0%) | $35.93 M(-733.1%) |
| Feb 2012 | - | $730.00 K(-117.0%) | -$5.68 M(-18.4%) |
| Nov 2011 | - | -$4.30 M(-1543.6%) | -$6.95 M(+61.4%) |
| Aug 2011 | - | $298.00 K(-112.4%) | -$4.31 M(-9.6%) |
| May 2011 | -$4.76 M | -$2.40 M(+339.9%) | -$4.76 M(-127.9%) |
| Feb 2011 | - | -$546.00 K(-67.0%) | $17.07 M(+1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2010 | - | -$1.66 M(+942.1%) | $16.88 M(-10.9%) |
| Aug 2010 | - | -$159.00 K(-100.8%) | $18.94 M(-3.7%) |
| May 2010 | $19.67 M(+901.1%) | $19.44 M(-2726.6%) | $19.67 M(+3654.2%) |
| Feb 2010 | - | -$740.00 K(-282.3%) | $524.00 K(-69.4%) |
| Nov 2009 | - | $406.00 K(-28.6%) | $1.71 M(+102.4%) |
| Aug 2009 | - | $569.00 K(+96.9%) | $847.00 K(-56.9%) |
| May 2009 | $1.97 M(-112.7%) | $289.00 K(-35.8%) | $1.97 M(-24.5%) |
| Feb 2009 | - | $450.00 K(-197.6%) | $2.60 M(-60.4%) |
| Nov 2008 | - | -$461.00 K(-127.3%) | $6.58 M(+2.1%) |
| Aug 2008 | - | $1.69 M(+81.8%) | $6.44 M(-141.6%) |
| May 2008 | -$15.47 M(-852.0%) | $928.00 K(-79.0%) | -$15.47 M(-7.8%) |
| Feb 2008 | - | $4.42 M(-840.9%) | -$16.78 M(-25.5%) |
| Nov 2007 | - | -$597.00 K(-97.0%) | -$22.52 M(+38.3%) |
| Aug 2007 | - | -$20.22 M(+5221.6%) | -$16.28 M(-891.3%) |
| May 2007 | $2.06 M(-9.5%) | -$380.00 K(-71.1%) | $2.06 M(-28.2%) |
| Feb 2007 | - | -$1.32 M(-123.3%) | $2.87 M(-572.9%) |
| Nov 2006 | - | $5.64 M(-398.9%) | -$606.00 K(-163.2%) |
| Aug 2006 | - | -$1.89 M(-539.9%) | $959.00 K(-57.8%) |
| May 2006 | $2.27 M(-257.9%) | $429.00 K(-109.0%) | $2.27 M(+139.7%) |
| Feb 2006 | - | -$4.79 M(-166.5%) | $948.00 K(-37.1%) |
| Nov 2005 | - | $7.21 M(-1355.4%) | $1.51 M(-153.3%) |
| Aug 2005 | - | -$574.00 K(-35.9%) | -$2.83 M(+96.5%) |
| May 2005 | -$1.44 M(-64.8%) | -$895.00 K(-78.8%) | -$1.44 M(-11.8%) |
| Feb 2005 | - | -$4.23 M(-247.3%) | -$1.63 M(-68.4%) |
| Nov 2004 | - | $2.87 M(+252.8%) | -$5.16 M(+83.9%) |
| Aug 2004 | - | $814.00 K(-174.8%) | -$2.81 M(-31.3%) |
| May 2004 | -$4.09 M(-12.7%) | -$1.09 M(-86.0%) | -$4.09 M(+13.9%) |
| Feb 2004 | - | -$7.76 M(-248.5%) | -$3.59 M(-721.8%) |
| Nov 2003 | - | $5.23 M(-1221.9%) | $577.00 K(-113.4%) |
| Aug 2003 | - | -$466.00 K(-20.9%) | -$4.32 M(-55.3%) |
| May 2003 | -$4.68 M(-43.4%) | - | - |
| Apr 2003 | - | -$589.00 K(-83.6%) | -$9.66 M(+222.0%) |
| Jan 2003 | - | -$3.60 M(-1179.9%) | -$3.00 M(-63.7%) |
| Oct 2002 | -$8.26 M(-171.1%) | $333.00 K(-105.7%) | -$8.26 M(+59.2%) |
| Jul 2002 | - | -$5.81 M(-195.7%) | -$5.19 M(-247.9%) |
| Apr 2002 | - | $6.07 M(-168.5%) | $3.51 M(-822.0%) |
| Jan 2002 | - | -$8.86 M(-360.1%) | -$486.00 K(-104.2%) |
| Oct 2001 | $11.62 M(-28.6%) | $3.41 M(+17.9%) | $11.62 M(+111.1%) |
| Jul 2001 | - | $2.89 M(+39.2%) | $5.51 M(-20.1%) |
| Apr 2001 | - | $2.08 M(-36.1%) | $6.89 M(+8.7%) |
| Jan 2001 | - | $3.25 M(-219.9%) | $6.34 M(-61.1%) |
| Oct 2000 | $16.29 M(+2048.8%) | -$2.71 M(-163.4%) | $16.29 M(-15.0%) |
| Jul 2000 | - | $4.28 M(+180.5%) | $19.16 M(+27.9%) |
| Apr 2000 | - | $1.52 M(-88.5%) | $14.98 M(+11.3%) |
| Jan 2000 | - | $13.20 M(+8254.4%) | $13.46 M(+1675.5%) |
| Oct 1999 | $758.00 K(-77.0%) | $158.00 K(+58.0%) | $758.00 K(-80.6%) |
| Jul 1999 | - | $100.00 K(>+9900.0%) | $3.90 M(-2.5%) |
| Apr 1999 | - | $0.00(-100.0%) | $4.00 M(-2.4%) |
| Jan 1999 | - | $500.00 K(-84.8%) | $4.10 M(+24.2%) |
| Oct 1998 | $3.30 M(-135.9%) | $3.30 M(+1550.0%) | $3.30 M(+3200.0%) |
| Jul 1998 | - | $200.00 K(+100.0%) | $100.00 K(-120.0%) |
| Apr 1998 | - | $100.00 K(-133.3%) | -$500.00 K(-94.7%) |
| Jan 1998 | - | -$300.00 K(-400.0%) | -$9.50 M(+3.3%) |
| Oct 1997 | -$9.20 M(-126.4%) | $100.00 K(-125.0%) | -$9.20 M(-1.1%) |
| Jul 1997 | - | -$400.00 K(-95.5%) | -$9.30 M(+4.5%) |
| Apr 1997 | - | -$8.90 M(<-9900.0%) | -$8.90 M(<-9900.0%) |
| Jan 1997 | - | $0.00 | $0.00 |
| Oct 1996 | $34.90 M | - | - |
FAQ
- What is Lifecore Biomedical annual cash flow from financing activities?
- What is the all time high annual CFF for Lifecore Biomedical?
- What is Lifecore Biomedical annual CFF year-on-year change?
- What is Lifecore Biomedical quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Lifecore Biomedical?
- What is Lifecore Biomedical quarterly CFF year-on-year change?
- What is Lifecore Biomedical TTM cash flow from financing activities?
- What is the all time high TTM CFF for Lifecore Biomedical?
- What is Lifecore Biomedical TTM CFF year-on-year change?
What is Lifecore Biomedical annual cash flow from financing activities?
The current annual CFF of LFCR is $7.51 M
What is the all time high annual CFF for Lifecore Biomedical?
Lifecore Biomedical all-time high annual cash flow from financing activities is $79.03 M
What is Lifecore Biomedical annual CFF year-on-year change?
Over the past year, LFCR annual cash flow from financing activities has changed by -$32.19 M (-81.09%)
What is Lifecore Biomedical quarterly cash flow from financing activities?
The current quarterly CFF of LFCR is $12.52 M
What is the all time high quarterly CFF for Lifecore Biomedical?
Lifecore Biomedical all-time high quarterly cash flow from financing activities is $61.60 M
What is Lifecore Biomedical quarterly CFF year-on-year change?
Over the past year, LFCR quarterly cash flow from financing activities has changed by +$4.88 M (+63.87%)
What is Lifecore Biomedical TTM cash flow from financing activities?
The current TTM CFF of LFCR is $20.63 M
What is the all time high TTM CFF for Lifecore Biomedical?
Lifecore Biomedical all-time high TTM cash flow from financing activities is $97.89 M
What is Lifecore Biomedical TTM CFF year-on-year change?
Over the past year, LFCR TTM cash flow from financing activities has changed by -$12.06 M (-36.90%)